Alexander & Baldwin (ALEX)

• Market cap: $1.27B
• 1 day: -0.97%
• 5 days: -3.38%
• 1 month: -1.91%
• 3 months: -7.53%
• 6 months: -11.87%
• Year to date: -1.08%
• 1 year: 9.55%
• 5 years: 72.67%
• 10 years: -1.97%
• Sector: Financials
• Industry: Real Estate Investment Trusts

About: Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

Employees: 99

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

47% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 66

19% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 27

0% more funds holding

Funds holding: 243 [Q3] → 244 (+1) [Q4]

0.4% more ownership

Funds ownership: 85.08% [Q3] → 85.49% (+0.4%) [Q4]

7% less capital invested

Capital invested by funds: $1.18B [Q3] → $1.1B (-$80.2M) [Q4]

71% less call options, than puts

Call options by funds: $58K | Put options by funds: $201K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $24 38% upside
• Avg. target: $24 38% upside
• High target: $24 38% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Piper Sandler Alexander Goldfarb 43% 1-year accuracy 20 / 47 met price target

38% upside $24

Overweight Maintained

28 Feb 2025